Athena Athena

X

Find Radio Compass News for Clindamycin Phosphate

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
150
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • INJECTABLE;INJECTION - EQ 150MG BASE/ML
  • SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • GEL;TOPICAL - 5%;1.2%
  • GEL;TOPICAL - 5%;EQ 1% BASE
  • SUPPOSITORY;VAGINAL - 100MG
  • CREAM;VAGINAL - EQ 2% BASE
  • AEROSOL, FOAM;TOPICAL - 1%
  • GEL;TOPICAL - 1.2%;0.025%

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-13-2024-4844.pdf

FDA
13 Mar 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf

FDA
28 Feb 2024

https://www.businesswire.com/news/home/20240110750811/en

BUSINESSWIRE
10 Jan 2024

https://www.accesswire.com/viewarticle.aspx?id=795118&lang=en

ACCESSWIRE
20 Oct 2023

https://www.globenewswire.com//news-release/2023/10/16/2760615/30757/en/Dar%C3%A9-Bioscience-Announces-Achievement-of-First-Commercial-Milestone-Under-License-Agreement-for-XACIATO-Clindamycin-Phosphate-Vaginal-Gel-2-FDA-Approved-Treatment-for-Bacterial-Vag.html

GLOBENEWSWIRE
16 Oct 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-6-2023-36272.pdf

FDA
06 Sep 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214401

FDA
05 Apr 2023

https://www.businesswire.com/news/home/20220811005562/en/Amneal-launches-4-new-Generic-products-including-Vasopressin-single-dose

BUSINESSWIRE
11 Aug 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214668

FDA
05 Aug 2022

https://www.globenewswire.com/news-release/2022/06/30/2472080/30757/en/Dar%C3%A9-Bioscience-Announces-Closing-of-Global-License-Agreement-with-Organon-to-Commercialize-XACIATO-clindamycin-phosphate-vaginal-gel-2-FDA-Approved-Treatment-for-Females-12-and-Ol.html

GLOBENEWSWIRE
30 Jun 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212845

FDA
10 Feb 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215607

FDA
18 Jan 2022

https://www.globenewswire.com/news-release/2021/12/07/2347833/30757/en/Dar%C3%A9-Announces-FDA-Approval-of-XACIATO-clindamycin-phosphate-Vaginal-Gel-as-a-Treatment-for-Bacterial-Vaginosis.html

GLOBENEWSWIRE
07 Dec 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=142681&sid=2

PHARMABIZ
21 Sep 2021

https://www.globenewswire.com/news-release/2021/08/23/2284805/0/en/Solaris-Pharma-Receives-Approval-for-First-Generic-Version-of-Clindagel-clindamycin-phosphate-EQ-1.html

GLOBENEWSWIRE
23 Aug 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212438

FDA
17 Mar 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214251

FDA
16 Feb 2021

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-usfda-nod-for-acne-treatment-drug/articleshow/80833080.cms

INDIATIMES
10 Feb 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214052

FDA
12 Nov 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211872

FDA
29 Jul 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210004

FDA
17 Mar 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209610

FDA
24 Sep 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205397

FDA
11 Sep 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207194

FDA
21 Aug 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206575

FDA
21 Aug 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210778

FDA
19 Jun 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-10-2019-1554872020.pdf

FDA
10 Apr 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209914

FDA
28 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210794

FDA
31 Dec 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207194

FDA
20 Oct 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208757

FDA
03 Aug 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208767

FDA
21 Jul 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208776

FDA
31 May 2018

http://www.ttpharm.com/nd.jsp?id=44

PRESS RELEASE
17 Apr 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf

FDA
28 Feb 2018

https://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-the-generic-version-of-onexton-gel-300588900.html

PR NEWSWIRE
26 Jan 2018

https://www.prnewswire.com/news-releases/perrigo-announces-patent-litigation-settlement-for-the-generic-version-of-onexton-gel-300543948.html

PR NEWSWIRE
26 Oct 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204748

FDA
12 Oct 2017

http://www.prnewswire.com/news-releases/perrigo-announces-tentative-fda-approval-for-the-generic-version-of-acanya-gel-300521093.html

PR NEWSWIRE
18 Sep 2017

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-12-2017-1499837241.pdf

FDA
12 Jul 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208084

FDA
30 Jun 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204087

FDA
29 Jun 2017

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2017-1490161550.pdf

FDA
22 Mar 2017

http://www.fiercepharma.com/manufacturing/perrigo-recalling-162-000-tubes-acne-gel

Eric Palmer FIERCE PHARMA
19 Jan 2017

http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206945

FDA
30 Dec 2016

http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208683

FDA
28 Dec 2016

http://www.reuters.com/article/2015/11/12/valeant-pharmacies-officers-idUSL1N13706P20151112#oiVQh9Bs7fswguHF.97

Carl O\'Donnell REUTERS
12 Nov 2015

https://www.pharmacompass.com/pdf/news/perrigos-generic-clindamycin-phosphate-and-benzoyl-peroxide-approved-in-us-for-acne-1443095021.pdf

23 Sep 2015

http://www.prnewswire.com/news-releases/perrigo-announces-fda-approval-and-launch-of-the-ab-rated-generic-version-of-benzaclin-topical-gel-300146992.html

PR NEWS WIRE
22 Sep 2015

http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202564Orig1s000ltr.pdf

Press Release FDA
17 Jun 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY